Pharmacist Digest

CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines

Pharma Times

APRIL 19, 2024

Both will develop cancer vaccine candidates in selected haematological and solid tumour indications

Vaccines

New clinical trial aims to investigate skin patches to spot lung transplant rejection

Pharma Times

APRIL 19, 2024

Involving 152 patients, the SENTINEL trial aims to cut lung transplant rejection by up to 50%

New UK report highlights inequalities among people living with breast cancer

Pharma Times

APRIL 18, 2024

Breast cancer was responsible for 2.

Researchers introduce new AI tool to help clinicians capture uncertainty in medical images

Pharma Times

APRIL 18, 2024

The Tyche model could help clinicians and researchers capture crucial information in images

Hospitals

Study reveals how specific nasal cells protect against COVID-19 in paediatric patients

Pharma Times

APRIL 17, 2024

The findings suggest why children tend to experience milder symptoms compared to older adults

ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery

Pharma Times

APRIL 17, 2024

Both companies will facilitate career progression while advancing the life sciences industry

US study reveals age-related skin changes could contribute to melanoma metastases

Pharma Times

MARCH 13, 2024

Around 200,000 people in the US are expected to be diagnosed with the skin cancer this year

AbbVie’s Produodopa approved by SMC to treat Parkinson’s disease patients in Scotland

Pharma Times

MARCH 13, 2024

The progressive neurological disorder affects approximately 12,400 people in Scotland

ICR awarded $25m by Cancer Grand Challenges to research solid tumours in children

Pharma Times

MARCH 12, 2024

Globally, cancer is currently the most leading cause of death due to disease among children

NHS campaign urges over 900,000 young adults to catch up on missed MMR vaccine

Pharma Times

MARCH 12, 2024

Between October 2023 and March 2024, the UKHSA said that 733 cases of measles were reported in England

Vaccines

Elicio’s vaccine shows promise as potential cancer treatment in phase 1 trial

Pharma Times

FEBRUARY 21, 2024

Results showed robust responses in patients with pancreatic and colorectal cancer

Vaccines

Researchers launch global iSPY network to research Strep A infections

Pharma Times

FEBRUARY 21, 2024

A streptococcal bacterial infections are estimated to affect around 50 million people worldwide

Immunity

Immunity Immunization

Scientists develop micofluidic chip to make cell therapy safer

Pharma Times

FEBRUARY 12, 2024

The chip removes cells, which could become tumours, before they are implanted in a patient

Phesi’s AI-driven Trial Accelerator platform contains over 100 million patients

Pharma Times

FEBRUARY 12, 2024

The platform delivers digitalised patient data to improve clinical trials and development

NHS launches BRCA testing programme for people of Jewish descent

Pharma Times

FEBRUARY 2, 2024

Individuals with Jewish ancestry are six times more likely to carry a genetic fault

Study reveals SARS-CoV-2 can infect dopamine neurons causing senescence

Pharma Times

FEBRUARY 2, 2024

Dopamine neuron senescence is a hallmark of Parkinson’s disease

Owkin and Evotec partner to accelerate therapeutics in oncology and I&I

Pharma Times

JANUARY 5, 2024

The companies will aim to select targets, discover and develop new therapeutics

Immune cell helps predict skin cancer patients’ responses to immunotherapies

Pharma Times

JANUARY 5, 2024

Vd1-gd T cells were effective in predicting positive responses to ICI therapy

Immunity

Immunity Immunization Hospitals

Cognitive decline in early Alzheimer’s could stem from serotonin loss

Pharma Times

DECEMBER 18, 2023

MCI patients had 25% lower levels of serotonin compared to healthy patients - News - PharmaTimes

Digital health collaboration to trial AI-powered X-rays for lung cancer detection

Pharma Times

DECEMBER 18, 2023

Earlier diagnosis could increase patient survival rates by five years or more - News - PharmaTimes

PREDICTOM trial backed by €21m for early Alzheimer’s detection

Pharma Times

NOVEMBER 22, 2023

The trial will use an AI screening platform to identify those most at risk of dementia - News - PharmaTimes

Thousands of men to participate in UK trial for prostate cancer

Pharma Times

NOVEMBER 22, 2023

Prostate cancer is responsible for 12,000 deaths every year in the UK - News - PharmaTimes

Two charities co-fund £5.5m childhood cancer research programme

Pharma Times

NOVEMBER 21, 2023

SMPaeds2 aims to advance precision medicines for children with relapsed cancer - News - PharmaTimes

Lab-grown blood vessels could potentially treat strokes and vascular dementia

Pharma Times

NOVEMBER 21, 2023

Cerebral SVD contributes to 45% of dementia cases and 20% of ischaemic strokes - News - PharmaTimes

NHS expands COVID-19 research platform for other major diseases

Pharma Times

NOVEMBER 20, 2023

The OpenSAFELY platform will support the discovery of new treatments - News - PharmaTimes

BHF and UKDRI announce first UK centre for vascular dementia research

Pharma Times

NOVEMBER 20, 2023

The centre will help discover new treatments to prevent, halt and cure the condition - News - PharmaTimes

NHS roaming trucks identify over 2000 people at risk of liver cancer

Pharma Times

OCTOBER 30, 2023

The NHS has been visiting at-risk communities to detect liver cancer earlier - News - PharmaTimes

NIHR data reveals commercial study set up times reduce by a third

Pharma Times

OCTOBER 30, 2023

Over 600 commercial studies have been reviewed in the past 12 months - News - PharmaTimes

Study reveals diagnosis and treatment inequalities in NHS heart care

Pharma Times

OCTOBER 10, 2023

Researchers focused on four of the most common heart conditions in the UK - News - PharmaTimes

UKRI awards £41m to enhance UK research and innovation

Pharma Times

OCTOBER 10, 2023

The scheme will help ten projects establish research and innovation clusters - News - PharmaTimes

Evox Therapeutics reaches gene therapy agreement

Pharma Times

AUGUST 7, 2023

Partnership with Icahn School of Medicine will involve developing exoAAV vectors for heart disease patients - News - PharmaTimes

Taiho begins latest non-small cell lung cancer trial

Pharma Times

AUGUST 7, 2023

A combination of zipalertinib and chemotherapy will be evaluated as a treatment for adults - News - PharmaTimes

Chemotherapy

CatalYm highlights GDF-15 as main anti-PD-1 resistance factor

Pharma Times

JULY 21, 2023

Data underlines the significance of the company’s anti-GDF-15 antibody candidate, visugromab - News - PharmaTimes

Teva UK launches GoResp Digihaler

Pharma Times

JULY 21, 2023

The inhaler supports appropriate individuals presenting with asthma and chronic obstructive pulmonary disease - News - PharmaTimes

Grifols announces phase 3 progress for Albutein

Pharma Times

JULY 20, 2023

Therapy has the potential to decrease mortality rates in patients with decompensated cirrhosis - News - PharmaTimes

UCB announces EMA bimekizumab verdict

Pharma Times

JULY 20, 2023

In two studies the therapy demonstrated improvements when compared with the placebo - News - PharmaTimes

Glaucoma therapy Roclanda launched by Santen

Pharma Times

JULY 19, 2023

By combining both netarsudil and latanoprost treatment, Roclanda reduces intraocular pressure - News - PharmaTimes

Members of the Alliance for Genomic Discovery revealed

Pharma Times

JULY 19, 2023

Illumina and Nashville Biosciences’ have announced AbbVie, Amgen, AstraZeneca, Bayer and Merck as founding members - News - PharmaTimes

King’s College London and Pioneer Group in incubator link-up

Pharma Times

JULY 4, 2023

Collaboration aims to revitalise two empty sites on the South Bank of London by providing several laboratories - News - PharmaTimes

Teva reveals critical Ajovy data

Pharma Times

JULY 4, 2023

Therapy has been developed to reduce the frequency, duration and severity of migraine attacks - News - PharmaTimes

genedrive awarded test kit grant

Pharma Times

JUNE 16, 2023

DEVOTE grant will allow acute care patient access and a supporting infrastructure for the company - News - PharmaTimes

Rosemont acquires Lucis Pharma to boost portfolio

Pharma Times

JUNE 16, 2023

Company will gain access to a considerable pipeline of liquid products covering various disease areas - News - PharmaTimes

NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks

Pharma Times

JUNE 2, 2023

The final draft guidance recommends rimegepant for adults who have at least four migraine attacks per month, but less than 15 - News - PharmaTimes

BioInvent receives Investigational New Drug approval for monoclonal antibody BI-1910

Pharma Times

JUNE 2, 2023

BI-1910 is now the second of the company's anti-tumour necrosis factor receptor 2 programmes to enter clinical development - News - PharmaTimes

Pharma Times

CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines

New clinical trial aims to investigate skin patches to spot lung transplant rejection

Trending Sources

New UK report highlights inequalities among people living with breast cancer

Researchers introduce new AI tool to help clinicians capture uncertainty in medical images

Study reveals how specific nasal cells protect against COVID-19 in paediatric patients

ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery

US study reveals age-related skin changes could contribute to melanoma metastases

AbbVie’s Produodopa approved by SMC to treat Parkinson’s disease patients in Scotland

ICR awarded $25m by Cancer Grand Challenges to research solid tumours in children

NHS campaign urges over 900,000 young adults to catch up on missed MMR vaccine

Elicio’s vaccine shows promise as potential cancer treatment in phase 1 trial

Researchers launch global iSPY network to research Strep A infections

Scientists develop micofluidic chip to make cell therapy safer

Phesi’s AI-driven Trial Accelerator platform contains over 100 million patients

NHS launches BRCA testing programme for people of Jewish descent

Study reveals SARS-CoV-2 can infect dopamine neurons causing senescence

Owkin and Evotec partner to accelerate therapeutics in oncology and I&I

Immune cell helps predict skin cancer patients’ responses to immunotherapies

Cognitive decline in early Alzheimer’s could stem from serotonin loss

Digital health collaboration to trial AI-powered X-rays for lung cancer detection

PREDICTOM trial backed by €21m for early Alzheimer’s detection

Thousands of men to participate in UK trial for prostate cancer

Two charities co-fund £5.5m childhood cancer research programme

Lab-grown blood vessels could potentially treat strokes and vascular dementia

NHS expands COVID-19 research platform for other major diseases

BHF and UKDRI announce first UK centre for vascular dementia research

NHS roaming trucks identify over 2000 people at risk of liver cancer

NIHR data reveals commercial study set up times reduce by a third

Study reveals diagnosis and treatment inequalities in NHS heart care

UKRI awards £41m to enhance UK research and innovation

Evox Therapeutics reaches gene therapy agreement

Taiho begins latest non-small cell lung cancer trial

CatalYm highlights GDF-15 as main anti-PD-1 resistance factor

Teva UK launches GoResp Digihaler

Grifols announces phase 3 progress for Albutein

UCB announces EMA bimekizumab verdict

Glaucoma therapy Roclanda launched by Santen

Members of the Alliance for Genomic Discovery revealed

King’s College London and Pioneer Group in incubator link-up

Teva reveals critical Ajovy data

genedrive awarded test kit grant

Rosemont acquires Lucis Pharma to boost portfolio

NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks

BioInvent receives Investigational New Drug approval for monoclonal antibody BI-1910

Stay Connected